Skip to main content

Published locations for Investigational uricase-based gout drug meets primary endpoints in phase 3 trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Investigational uricase-based gout drug meets primary endpoints in phase 3 trials

User login

  • Reset your password
  • /content/investigational-uricase-based-gout-drug-meets-primary-endpoints-phase-3-trials
  • /clinicianreviews/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints
  • /familypracticenews/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary
  • /fedprac/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints-phase-3
  • /internalmedicinenews/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary
  • /rheumatologynews/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints
  • /rheumatology/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints
  • /internalmedicine/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints
  • /familymedicine/article/263395/gout/investigational-uricase-based-gout-drug-meets-primary-endpoints